22.728 articles found

NEW DERIVATIVES OF PROPARGYLAMINE HAVING NEUROPROTECTIVE CAPACITY FOR THE TREATMENT OF ALZHEIMER'S AND PARKINSON'S DISEASES

SAMADI ABDELOUAHID, MARCO CONTELLES JOSE LUIS, BOLEA TOMAS IRENE, LUQUE GARRIGA FRANCISCO JAVIER, UNZETA LOPEZ MERCEDES.

· 2011-03-18

Recombinant adeno-associated virus-mediated gene transfer for the potential therapy of adenosine deaminase-deficient severe combined immune deficiency.

Silver JN, Elder M, Conlon T, Cruz P, Wright AJ, Srivastava A, Flotte TR.

Hum Gene Ther · 2011-03-13

DOI: 10.1089/hum.2010.121PMID: 21142972

Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment.

Greene LA, Levy O, Malagelada C.

Cell Mol Neurobiol · 2011-03-10

DOI: 10.1007/s10571-011-9671-8PMID: 21547489

TRANSDERMAL COMPOSITION CONTAINING THERAPEUTIC AGENT FOR PARKINSON'S DISEASE

YAMASAKI KEIKO.

· 2011-03-09

Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.

Cerasa A, Messina D, Pugliese P, Morelli M, Lanza P, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Mov Disord · 2011-03-07

DOI: 10.1002/mds.23660PMID: 21384430

HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.

Li G, Jiang H, Chang M, Xie H, Hu L.

J Neurol Sci · 2011-03-05

DOI: 10.1016/j.jns.2011.02.017PMID: 21377170

Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.

Muñoz-Soriano V, Paricio N.

Parkinsons Dis · 2011-03-03

DOI: 10.4061/2011/520640PMID: 21512585

Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.

Cleva RM, Olive MF.

Molecules · 2011-03-02

DOI: 10.3390/molecules16032097PMID: 21368721

Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.

Stowe R, Ives N, Clarke CE, Handley K, Furmston A, Deane K, van Hilten JJ, Wheatley K, Gray R.

Mov Disord · 2011-03-02

DOI: 10.1002/mds.23517PMID: 21370258

Case report of electroconvulsive therapy in a patient with Parkinson disease concomitant with deep brain stimulation.

Nasr S, Murillo A, Katariwala N, Mothkur V, Wendt B.

J ECT · 2011-03-01

DOI: 10.1097/yct.0b013e3181da843cPMID: 20386114

Bupropion in the treatment of depression in Parkinson's disease.

Załuska M, Dyduch A.

Int Psychogeriatr · 2011-03-01

DOI: 10.1017/s1041610210001687PMID: 20809995

p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases.

Yasuda S, Sugiura H, Tanaka H, Takigami S, Yamagata K.

Cent Nerv Syst Agents Med Chem · 2011-03-01

DOI: 10.2174/187152411794961040PMID: 20812905